Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| guided prostate biopsy |
|
Prostate Ultrasound If a suspicious lesion is identified with ultrasound or with a rectal examination, an ultrasound-guided biopsy can be performed. Transient impotence after transrectal ultrasound-guided prostate function after TRUS-guided prostate biopsy to. find out the real incidence. Furthermore, tran-. sient impotence should be included as a possible 08/07 Three-T-guided prostate biopsy wins more support MR-guided biopsies at 3T are showing great promise in prostate cancer because of their speed and high tumor detection rate in patients with rising Clinical Radiology : Ultrasound-guided prostate biopsy in 2005 Ultrasound-guided prostate biopsy may be performed by radiologists or urologists, and is now the commonest biopsy procedure undertaken in men. Control of Pain during Transrectal Ultrasound-Guided Prostate Control of Pain during Transrectal Ultrasound-Guided Prostate Biopsy: A Prospective Study Comparing Two Methods K.K. Bhomi, H.H. Lim, D.T. Consigliere, Prostate Cancer and Prostatic Diseases - Abstract of article Factors influencing pain during transrectal ultrasonography-guided prostate biopsy. K S Han1 and K H Lee1 The Korean Urologic Oncology Society Prostate IngentaConnect Clinical outcome of transrectal ultrasound-guided Clinical outcome of transrectal ultrasound-guided prostate biopsy, targeting eight cores, for detecting prostate cancer in Japanese men Transrectal Ultrasound and Biopsy in the Early Diagnosis of History of TRUS-Guided Prostate Biopsy. Ferguson 9 performed the first prostate needle biopsy in 1930. He described a transperineal approach with an 65 Multi-resistant Escherichia coli septicaemia following ultrasound guided prostate biopsy â“ an. emerging risk. A.-J. DAVIDSON*, N. LAWRENTSCHUK*, of TRUS guided biopsy of the prostate was. also performed. Development of a New Image-Guided Prostate Biopsy System In this work, we are developing a new image-guided prostate biopsy system Image-guided prostate biopsy system with 3-D cancer distribution atlas Pain Scores and Local Anesthesia for Transrectal Ultrasound fective method of anesthesia delivery before TRUS-guided prostate biopsy in patients . anaesthetic for transrectal ultrasound-guided prostate biopsy: A NEJM -- MRI-Guided Diagnosis and Treatment of Prostate Cancer MRI-guided prostate biopsy using surgical navigation software: device MR Imaging-guided Prostate Biopsy with a Closed MR Unit at 1.5 T: Initial Results. Development of a New Image-Guided Prostate Biopsy System Development of a New Image-Guided Prostate Biopsy System. Source, Lecture Notes In Computer Science; Vol. 2208 archive Proceedings of the 4th International Prostate biopsy "Pain During Transrectal Ultrasonography Guided Prostate Biopsy: A Randomized Prospective Trial Comparing Periprostatic Infiltration with Lidocaine with the MR Imaging-guided Prostate Biopsy with a Closed MR Unit at 1.5 T MR Imagingâ“guided Prostate Biopsy with a Closed MR Unit at 1.5 T: Initial Results1. Dirk Beyersdorff, MD, Axel Winkel, Bernd Hamm, MD, Severin Lenk, MD, Disinfection of equipment used for prostate biopsy | AORN Journal A TRUS-guided prostate biopsy is performed to evaluate patients for prostate cancer, Disinfection of a probe used in ultrasound-guided prostate biopsy. |
| guided prostate biopsy |
|
medication prostate new chapter prostate 5lx prostate anatomy incontinence prostate surgery |